Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer
Zeyu Chen, Eri Arai, Omar Khan, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1262-1280.e22
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 361
The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes
Qizhao Huang, Xia Wu, Zhiming Wang, et al.
Cell (2022) Vol. 185, Iss. 22, pp. 4049-4066.e25
Open Access | Times Cited: 233
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
Julia A. Belk, Winnie Yao, Nghi Ly, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 768-786.e7
Open Access | Times Cited: 212
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 203
Epigenetic regulation of T cell exhaustion
Julia A. Belk, Bence Dániel, Ansuman T. Satpathy
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 848-860
Open Access | Times Cited: 176
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 155
Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics
Josephine R. Giles, Shin Foong Ngiow, Sasikanth Manne, et al.
Nature Immunology (2022) Vol. 23, Iss. 11, pp. 1600-1613
Open Access | Times Cited: 147
A genome-scale screen for synthetic drivers of T cell proliferation
Mateusz Legut, Zoran Gajic, Maria Guarino, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 728-735
Open Access | Times Cited: 135
RASA2 ablation in T cells boosts antigen sensitivity and long-term function
Julia Carnevale, Eric Shifrut, Nupura Kale, et al.
Nature (2022) Vol. 609, Iss. 7925, pp. 174-182
Open Access | Times Cited: 126
The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function
Mathias Wenes, Alison Jaccard, Tania Wyss, et al.
Cell Metabolism (2022) Vol. 34, Iss. 5, pp. 731-746.e9
Open Access | Times Cited: 116
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
Josephine R. Giles, Sasikanth Manne, Elizabeth Freilich, et al.
Immunity (2022) Vol. 55, Iss. 3, pp. 557-574.e7
Open Access | Times Cited: 86
Enhanced T cell effector activity by targeting the Mediator kinase module
Katherine A. Freitas, Julia A. Belk, Elena Sotillo, et al.
Science (2022) Vol. 378, Iss. 6620
Open Access | Times Cited: 85
Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells
Xingying Zhang, Chenze Zhang, Miaomiao Qiao, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1407-1422.e7
Open Access | Times Cited: 80
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Zaoqu Liu, Meixin Shi, Yuqing Ren, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
Martyna Strzelec, Jan Detka, Patrycja Mieszczak, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 78
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
Jack D. Chan, C. Scheffler, Isabelle Munoz, et al.
Nature (2024) Vol. 629, Iss. 8010, pp. 201-210
Open Access | Times Cited: 68
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 63
Efficient engineering of human and mouse primary cells using peptide-assisted genome editing
Zhen Zhang, Amy E. Baxter, Diqiu Ren, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 2, pp. 305-315
Closed Access | Times Cited: 61
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
Victor Tieu, Elena Sotillo, Jeremy Bjelajac, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1278-1295.e20
Closed Access | Times Cited: 40
Epigenome editing technologies for discovery and medicine
Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 8, pp. 1199-1217
Closed Access | Times Cited: 16
In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions
Hongling Huang, Peipei Zhou, Jun Wei, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1245-1261.e21
Open Access | Times Cited: 102
The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity
Sabelo Lukhele, Diala Abd Rabbo, Mengdi Guo, et al.
Immunity (2022) Vol. 55, Iss. 12, pp. 2369-2385.e10
Open Access | Times Cited: 65
TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors
Wenliang Wang, Aditi Chandra, Naomi Goldman, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1052-1062
Open Access | Times Cited: 64
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target
Giorgia Alvisi, Alberto Termanini, Cristiana Soldani, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1359-1372
Open Access | Times Cited: 62
The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates
H. Kay Chung, Bryan McDonald, Susan M. Kaech
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top